Cargando…
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
Over the last 20 years, intensive investigation and multiple clinical successes targeting protein kinases, mostly for cancer treatment, have identified small molecule kinase inhibitors as a prominent therapeutic class. In the course of those investigations, radiolabeled kinase inhibitors for positro...
Autores principales: | Bernard-Gauthier, Vadim, Bailey, Justin J., Berke, Sheldon, Schirrmacher, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332294/ https://www.ncbi.nlm.nih.gov/pubmed/26690113 http://dx.doi.org/10.3390/molecules201219816 |
Ejemplares similares
-
Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010) -
PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012) -
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
por: Judmann, Benedikt, et al.
Publicado: (2020) -
Radiolabeling of Nanoparticles and Polymers for PET Imaging
por: Stockhofe, Katharina, et al.
Publicado: (2014) -
Theragnostic Imaging Using Radiolabeled Antibodies and Tyrosine Kinase Inhibitors
por: Yoshimoto, Mitsuyoshi, et al.
Publicado: (2015)